| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.3 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |